Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM RegistryVanessa E. Kennedy, Hanneke Oude Elberink, William Shomali et al.|Blood Advances|2022Cited by 39
Proposed European Competence Network on Mastocytosis—American Initiative in Mast Cell Diseases (ECNM-AIM) Response Criteria in Advanced Systemic MastocytosisJason Gotlib, Andreas Reiter, Juliana Schwaab et al.|The Journal of Allergy and Clinical Immunology In Practice|2022Cited by 20
Clinical and histopathological features of myeloid neoplasms with concurrent Janus kinase 2 (<i>JAK2</i>) V617F and KIT proto‐oncogene, receptor tyrosine kinase (<i>KIT</i>) D816V mutationsNicole Naumann, Juliana Schwaab, Johannes Lübke et al.|British Journal of Haematology|2021Cited by 17